Horn Howard 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Dec 11, 2025
Insider Transaction Report
Form 4
Horn Howard
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-12-10$36.38/sh−3,081$112,087→ 95,146 total
Footnotes (1)
- [F1]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.